Arie Perry, MD - Publications

Affiliations: 
Pathology and Laboratory Medicine University of California, San Francisco, San Francisco, CA 
Area:
neuro-oncology
Website:
http://labmed.ucsf.edu/about/faculty/pathology-aperry.html

335 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Asa SL, Mete O, Riddle ND, Perry A. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Endocrine Pathology. PMID 37268858 DOI: 10.1007/s12022-023-09777-x  0.32
2022 Asa SL, Mete O, Schüller U, Ramani B, Mirchia K, Perry A. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin. The American Journal of Surgical Pathology. PMID 36543154 DOI: 10.1097/PAS.0000000000002009  0.315
2022 Keck MK, Sill M, Wittmann A, Joshi P, Stichel D, Beck P, Okonechnikow K, Sievers P, Wefers AK, Roncaroli F, Avula S, McCabe MG, Hayden JT, Wesseling P, Øra I, ... ... Perry A, et al. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathologica. PMID 36437415 DOI: 10.1007/s00401-022-02516-2  0.346
2022 Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, ... ... Perry A, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica. PMID 35945463 DOI: 10.1007/s00401-022-02478-5  0.326
2022 Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocrine Pathology. 33: 6-26. PMID 35291028 DOI: 10.1007/s12022-022-09703-7  0.314
2022 Pratt D, Abdullaev Z, Papanicolau-Sengos A, Ketchum C, Panneer Selvam P, Chung HJ, Lee I, Raffeld M, Gilbert MR, Armstrong TS, Pytel P, Borys E, Klonoski JM, McCord M, Horbinski C, ... ... Perry A, et al. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta Neuropathologica. PMID 35103816 DOI: 10.1007/s00401-022-02404-9  0.343
2021 Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, ... ... Perry A, et al. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathology (Zurich, Switzerland). e13037. PMID 34821426 DOI: 10.1111/bpa.13037  0.318
2021 Schmid S, Solomon DA, Perez E, Thieme A, Kleinschmidt-DeMasters BK, Giannini C, Reinhardt A, Asa SL, Mete O, Stichel D, Siewert C, Dittmayer C, Hasselblatt M, Paulus W, Nagel C, ... ... Perry A, et al. Genetic and epigenetic characterization of posterior pituitary tumors. Acta Neuropathologica. PMID 34661724 DOI: 10.1007/s00401-021-02377-1  0.321
2021 Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology. PMID 34185076 DOI: 10.1093/neuonc/noab106  0.307
2021 Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 34017065 DOI: 10.1038/s41379-021-00820-y  0.303
2020 Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, ... ... Perry A, et al. Intracranial mesenchymal tumor with FET-CREB fusion - a unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathology (Zurich, Switzerland). e12918. PMID 33141488 DOI: 10.1111/bpa.12918  0.342
2020 Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, ... ... Perry A, et al. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathologica. PMID 32892244 DOI: 10.1007/S00401-020-02221-Y  0.424
2020 Lucas CG, Gupta R, Doo P, Lee JC, Cadwell CR, Ramani B, Hofmann JW, Sloan EA, Kleinschmidt-DeMasters BK, Lee HS, Wood MD, Grafe M, Born D, Vogel H, Salamat S, ... ... Perry A, et al. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. Acta Neuropathologica Communications. 8: 151. PMID 32859279 DOI: 10.1186/S40478-020-01027-Z  0.379
2020 Toland A, McNulty SN, Pekmezci M, Evenson M, Huntoon K, Pierson CR, Boue DR, Perry A, Dahiya S. Pediatric meningioma: A clinicopathologic and molecular study with potential grading implications. Brain Pathology (Zurich, Switzerland). PMID 32716568 DOI: 10.1111/Bpa.12884  0.423
2020 Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, ... ... Perry A, et al. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discovery. PMID 32703768 DOI: 10.1158/2159-8290.Cd-20-0160  0.418
2020 Viaene AN, Pu C, Perry A, Li MM, Luo M, Santi M. Congenital Tumors of the Central Nervous System: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics. Brain Pathology (Zurich, Switzerland). PMID 32681571 DOI: 10.1111/Bpa.12885  0.462
2020 Ko K, Kitani T, Harris BT, Anaizi AN, Solomon D, Perry A, Toretsky J, Ozdemirli M. A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult. Acta Neuropathologica Communications. 8: 112. PMID 32680570 DOI: 10.1186/S40478-020-00991-W  0.366
2020 Vasudevan HN, Castro MRH, Lee JC, Villanueva-Meyer JE, Bush NAO, McDermott MW, Solomon DA, Perry A, Magill ST, Raleigh DR. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma. Acta Neuropathologica Communications. 8: 82. PMID 32517746 DOI: 10.1186/S40478-020-00952-3  0.323
2020 Gallo RA, Shoag J, Johnson TE, Solomon DA, Perry A, Podda A, Lee JY, Rong AJ. Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation. Ophthalmic Plastic and Reconstructive Surgery. PMID 32427730 DOI: 10.1097/Iop.0000000000001703  0.337
2020 Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, ... ... Perry A, et al. cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathology (Zurich, Switzerland). PMID 32307792 DOI: 10.1111/Bpa.12832  0.401
2020 Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, ... ... Perry A, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathologica. PMID 32303840 DOI: 10.1007/S00401-020-02155-5  0.347
2019 Lee JC, Villanueva-Meyer JE, Ferris SP, Cham EM, Zucker J, Cooney T, Gilani A, Kleinschmidt-DeMasters BK, Trembath D, Mafra M, Chiang J, Ellison DW, Cho SJ, Horvai AE, Van Ziffle J, ... ... Perry A, et al. Clinicopathologic and Molecular Features of Intracranial Desmoplastic Small Round Cell Tumors. Brain Pathology (Zurich, Switzerland). PMID 31837177 DOI: 10.1111/Bpa.12809  0.442
2019 Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, Guaraldi F, Hickman RA, ... ... Perry A, et al. Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary. PMID 31834538 DOI: 10.1007/S11102-019-01015-0  0.384
2019 Lucas CG, Solomon DA, Perry A. A review of recently described genetic alterations in central nervous system tumors. Human Pathology. PMID 31678207 DOI: 10.1016/J.Humpath.2019.10.009  0.434
2019 Lucas CG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S, McDermott M, Berger M, Cham E, Sun PP, Putnam A, Zhou H, Bollo R, Cheshier S, Poppe MM, ... ... Perry A, et al. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathology (Zurich, Switzerland). PMID 31609499 DOI: 10.1111/Bpa.12797  0.446
2019 Al-Battashi A, Al Hajri Z, Perry A, Al-Kindi H, Al-Ghaithi I. A Cerebellar High-Grade Neuroepithelial Tumour with BCOR Alteration in a five-year-old Child: A case report. Sultan Qaboos University Medical Journal. 19: e153-e156. PMID 31538015 DOI: 10.18295/Squmj.2019.19.02.012  0.31
2019 Halfpenny A, Ferris SP, Grafe M, Woltjer R, Selden N, Nazemi K, Perry A, Solomon DA, Gultekin SH, Moore S, Olson S, Lawce H, Lucas L, Corless CL, Wood MD. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 31435988 DOI: 10.1111/Neup.12586  0.448
2019 Cheaney B, Bowden S, Krause K, Sloan EA, Perry A, Solomon DA, Han SJ, Wood MD. An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion. Acta Neuropathologica Communications. 7: 110. PMID 31288852 DOI: 10.1186/S40478-019-0763-X  0.393
2019 Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Ziffle JV, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, ... ... Perry A, et al. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication - a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathology (Zurich, Switzerland). PMID 31104347 DOI: 10.1111/Bpa.12747  0.473
2019 Louis DN, Ellison DW, Brat DJ, Aldape K, Capper D, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, von Deimling A, Wesseling P. cIMPACT-NOW: A practical summary of diagnostic points from Round 1 updates. Brain Pathology (Zurich, Switzerland). PMID 31038238 DOI: 10.1111/Bpa.12732  0.383
2019 Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, ... ... Perry A, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathologica. PMID 30877433 DOI: 10.1007/S00401-019-01990-5  0.316
2019 Torre M, Meredith DM, Dubuc A, Solomon DA, Perry A, Vasudevaraja V, Serrano J, Snuderl M, Ligon KL, Alexandrescu S. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. Journal of Neuropathology and Experimental Neurology. PMID 30816933 DOI: 10.1093/Jnen/Nlz011  0.435
2019 Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, et al. Molecular and translational advances in meningiomas. Neuro-Oncology. 21: i4-i17. PMID 30649490 DOI: 10.1093/Neuonc/Noy178  0.38
2019 Iorgulescu JB, Torre M, Harary M, Smith TR, Aizer AA, Reardon DA, Barnholtz-Sloan JS, Perry A. The Misclassification of Diffuse Gliomas: Rates and Outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30635340 DOI: 10.1158/1078-0432.Ccr-18-3101  0.349
2019 Breshears JD, Liu SJ, Vasudevan H, Pekmezci M, Castro MG, Lang U, Chen W, Choudhury A, Magill ST, Braunstein S, Gopinath C, Nakamura JL, Sneed P, Perry A, McDermott MW, et al. Multiplatform Molecular Profiling of Vestibular Schwannoma Reveals 2 Subgroups of Tumors With Distinct Radiographic Features and a Methylation-Based Predictor of Local Recurrence Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_317  0.367
2019 Calixto-Hope L, Lee J, Sloan E, Hofmann J, Van Ziffle J, Onodera C, Grenert J, Devine P, Kline C, Banerjee A, Clarke J, Taylor J, Ann Oberheim-Bush N, Buerki R, Butowski N, ... ... Perry A, et al. PATH-38. ROSETTE-FORMING GLIONEURONAL TUMOR IS DEFINED BY FGFR1 ACTIVATING ALTERATIONS WITH FREQUENT ACCOMPANYING PI3K AND MAPK PATHWAY MUTATIONS Neuro-Oncology. 21: vi151-vi152. DOI: 10.1093/Neuonc/Noz175.634  0.365
2019 John Liu S, Vasudevan H, Pekmezci M, Choudhury A, Lien B, Breshears J, Swaney D, Magill S, Lang U, Chen W, Gopinath C, Castro M, Villanueva-Meyer J, Braunstein S, Sneed P, ... ... Perry A, et al. GENE-37. VESTIBULAR SCHWANNOMA IS COMPRISED OF NEURAL CREST AND IMMUNE SUBGROUPS Neuro-Oncology. 21: vi105-vi105. DOI: 10.1093/Neuonc/Noz175.439  0.38
2019 Vasudevan H, Lucas C, Liu S, Choudhury A, Magill S, Gopinath C, Nakamura J, Braunstein S, Perry A, Pekmezci M, Raleigh D. Postoperative Radiation Therapy Improves Progression-Free Survival in Malignant Peripheral Nerve Sheath Tumors International Journal of Radiation Oncology*Biology*Physics. 105: E801-E802. DOI: 10.1016/J.Ijrobp.2019.06.2494  0.348
2018 Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, et al. The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma. Acta Neuropathologica. PMID 30584643 DOI: 10.1007/S00401-018-1952-6  0.426
2018 Lee JC, Sharifai N, Dahiya S, Kleinschmidt-DeMasters BK, Rosenblum MK, Reis GF, Samuel D, Siongco AM, Santi M, Storm PB, Ferris SP, Bollen AW, Pekmezci M, Solomon DA, Tihan T, ... Perry A, et al. Clinicopathologic features of Anaplastic Myxopapillary Ependymomas. Brain Pathology (Zurich, Switzerland). PMID 30417460 DOI: 10.1111/Bpa.12673  0.442
2018 Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathologica. PMID 30259105 DOI: 10.1007/S00401-018-1913-0  0.357
2018 Gennatas ED, Wu A, Braunstein SE, Morin O, Chen WC, Magill ST, Gopinath C, Villaneueva-Meyer JE, Perry A, McDermott MW, Solberg TD, Valdes G, Raleigh DR. Preoperative and postoperative prediction of long-term meningioma outcomes. Plos One. 13: e0204161. PMID 30235308 DOI: 10.1371/Journal.Pone.0204161  0.311
2018 López GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, ... ... Perry A, et al. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathologica. PMID 30196423 DOI: 10.1007/S00401-018-1906-Z  0.409
2018 Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet (London, England). PMID 30060998 DOI: 10.1016/S0140-6736(18)30990-5  0.345
2018 Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC, Grenert JP, Kline CN, Mueller S, Banerjee A, Nicolaides T, Gupta N, Berger MS, Lee HS, Pekmezci M, ... ... Perry A, et al. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathology (Zurich, Switzerland). PMID 30051528 DOI: 10.1111/Bpa.12639  0.436
2018 Solomon DA, Korshunov A, Sill M, Jones DTW, Kool M, Pfister SM, Fan X, Bannykh S, Hu J, Danielpour M, Li R, Johnston J, Cham E, Cooney T, Sun PP, ... ... Perry A, et al. Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile. Acta Neuropathologica. PMID 30006677 DOI: 10.1007/S00401-018-1883-2  0.356
2018 Luks TL, McKnight TR, Jalbert LE, Williams A, Neill E, Lobo KA, Persson AI, Perry A, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas. Translational Oncology. 11: 941-949. PMID 29883968 DOI: 10.1016/J.Tranon.2018.05.005  0.354
2018 Pekmezci M, Villanueva-Meyer JE, Goode B, Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Chamyan G, Maher OM, Khatib Z, Kleinschmidt-DeMasters BK, Samuel D, Mueller S, Banerjee A, Clarke JL, ... ... Perry A, et al. The genetic landscape of ganglioglioma. Acta Neuropathologica Communications. 6: 47. PMID 29880043 DOI: 10.1186/S40478-018-0551-Z  0.349
2018 López GY, Perry A, Harding B, Li M, Santi M. CDKN2A/B Loss is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma. Neuropathology and Applied Neurobiology. PMID 29804288 DOI: 10.1111/Nan.12503  0.343
2018 Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. Journal of Neurosurgery. 1-8. PMID 29624151 DOI: 10.3171/2017.9.Jns171609  0.316
2018 Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, ... Perry A, et al. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Reports. 22: 3672-3683. PMID 29590631 DOI: 10.1016/J.Celrep.2018.03.013  0.35
2018 Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE. Salvage therapy outcomes for atypical meningioma. Journal of Neuro-Oncology. PMID 29480505 DOI: 10.1007/S11060-018-2813-9  0.337
2018 Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, ... ... Perry A, et al. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nature Communications. 9: 810. PMID 29476136 DOI: 10.1038/S41467-018-02826-8  0.405
2018 Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, et al. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup. The American Journal of Surgical Pathology. PMID 29324471 DOI: 10.1097/Pas.0000000000001023  0.415
2018 Fritchie K, Jensch K, Jenkins S, Link M, D Brown P, Rodriguez F, Guajardo A, Brat D, Velazquez Vega J, Perry A, Wu A, Raleigh D, Santagata S, Louis D, Brastianos P, et al. RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA Neuro-Oncology. 20: vi237-vi238. DOI: 10.1093/Neuonc/Noy148.985  0.43
2018 Antony R, Solomon D, Jin L, Perry A, Mueller S, Zwienenberg-Lee M, Ozturk A. HGG-12. PRIMARY BITHALAMIC GLIOMA WITH EGFR MUTATION: A RARE CASE REPORT Neuro-Oncology. 20: i91-i91. DOI: 10.1093/Neuonc/Noy059.284  0.316
2018 Peterson MS, Waddell JK, Ebbert TL, Perry A, Berg LC. Malignant peripheral nerve sheath tumor within the spinal canal with apparent drop metastases Human Pathology: Case Reports. 14: 88-91. DOI: 10.1016/J.Ehpc.2018.10.001  0.391
2017 Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, Theodosopoulos PV, McDermott MW, Braunstein SE, Raleigh DR. Presenting symptoms and prognostic factors for symptomatic outcomes following resection of meningioma. World Neurosurgery. PMID 29248774 DOI: 10.1016/J.Wneu.2017.12.012  0.339
2017 Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, et al. SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors. Sarcoma. 2017: 8685638. PMID 29138631 DOI: 10.1155/2017/8685638  0.365
2017 Korshunov A, Chavez L, Sharma T, Ryzhova M, Schrimpf D, Stichel D, Capper D, Sturm D, Kool M, Habel A, Kleinschmidt-DeMasters BK, Rosenblum M, Absalyamova O, Golanov A, Lichter P, ... ... Perry A, et al. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis. Brain Pathology (Zurich, Switzerland). PMID 28990704 DOI: 10.1111/Bpa.12566  0.433
2017 Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. Journal of Neurosurgery. 1-13. PMID 28984517 DOI: 10.3171/2016.11.Jns161170  0.399
2017 Wood MD, Tihan T, Perry AJ, Chacko G, Turner C, Pu C, Payne C, Yu A, Bannykh S, Solomon DA. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Brain Pathology (Zurich, Switzerland). PMID 28960623 DOI: 10.1111/Bpa.12561  0.426
2017 Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, ... ... Perry A, et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proceedings of the National Academy of Sciences of the United States of America. PMID 28916733 DOI: 10.1073/Pnas.1708914114  0.369
2017 Pekmezci M, Cuevas-Ocampo AK, Perry A, Horvai AE. Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28776579 DOI: 10.1038/Modpathol.2017.97  0.413
2017 Chan AK, Han SJ, Choy W, Beleford D, Aghi MK, Berger MS, Shieh JT, Bollen AW, Perry A, Phillips JJ, Butowski N, Solomon DA. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history. Clinical Neuropathology. PMID 28699883 DOI: 10.5414/Np301022  0.404
2017 Sorge C, Li R, Singh S, Reddy AT, Solomon DA, Perry A, Friedman GK. Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature. Pediatric Blood & Cancer. PMID 28696020 DOI: 10.1002/Pbc.26708  0.385
2017 Ferris SP, Hofmann JW, Solomon DA, Perry A. Characterization of gliomas: from morphology to molecules. Virchows Archiv : An International Journal of Pathology. PMID 28674742 DOI: 10.1007/S00428-017-2181-4  0.378
2017 Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A. Histopathologic Evaluation of Atypical Neurofibromatous Tumors and Their Transformation into Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1 Patients - A Consensus Overview. Human Pathology. PMID 28551330 DOI: 10.1016/J.Humpath.2017.05.010  0.413
2017 Dahlin LB, Scherman P, Besjakov J, Lindberg E, Solomon DA, Horvai AE, Perry A. Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case. Clinical Neuropathology. PMID 28438258 DOI: 10.5414/Np300989  0.427
2017 Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, et al. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro-Oncology. PMID 28339824 DOI: 10.1093/Neuonc/Now282  0.324
2017 Rutkowski MJ, Birk HS, Wood MD, Perry A, Nicolaides T, Ames CP, Gupta N. Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy. Journal of Neurosurgery. Pediatrics. 1-7. PMID 28304223 DOI: 10.3171/2017.1.Peds16549  0.336
2017 Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, et al. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta Neuropathologica. PMID 28255664 DOI: 10.1007/S00401-017-1690-1  0.384
2017 Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. Journal of Neuro-Oncology. PMID 28124178 DOI: 10.1007/S11060-016-2355-Y  0.32
2017 Vasudevan H, Braunstein S, Wu A, Reis G, Magill S, Phillips J, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. Molecular Profiling of Meningioma Identifies Genomic Signatures That Predict Clinical Outcomes Independent of Tumor Grade International Journal of Radiation Oncology*Biology*Physics. 99: S22. DOI: 10.1016/J.Ijrobp.2017.06.064  0.363
2016 Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, ... ... Perry A, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology. PMID 28170043 DOI: 10.1093/Neuonc/Now235  0.415
2016 Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, Wesseling P, Batchelor TT, Gregory Cairncross J, Pfister SM, Rutkowski S, et al. cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification. Brain Pathology (Zurich, Switzerland). PMID 27997995 DOI: 10.1111/Bpa.12457  0.389
2016 Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, Wesseling P, Batchelor TT, Cairncross JG, Pfister SM, Rutkowski S, et al. Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. Acta Neuropathologica. PMID 27909809 DOI: 10.1007/S00401-016-1646-X  0.393
2016 Hirbe AC, Kaushal M, Sharma MK, Dahiya S, Pekmezci M, Perry A, Gutmann DH. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Cancer. PMID 27875628 DOI: 10.1002/Cncr.30455  0.405
2016 Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW. Surgical resection of fourth ventricular ependymomas: case series and technical nuances. Journal of Neuro-Oncology. PMID 27778210 DOI: 10.1007/S11060-016-2198-6  0.365
2016 Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, et al. Mutant IDH1 expression drives TERT promoter reactivation as part of the cellular transformation process. Cancer Research. PMID 27758882 DOI: 10.1158/0008-5472.Can-16-0696  0.309
2016 Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP. Immunogenomics of Hypermutated Glioblastoma: a Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy. Cancer Discovery. PMID 27683556 DOI: 10.1158/2159-8290.Cd-16-0575  0.343
2016 Alshareef MA, Almadidy Z, Baker T, Perry A, Welsh CT, Vandergrift WA. Intracranial Angiomatoid Fibrous Histiocytoma: a Case report and literature review. World Neurosurgery. PMID 27667574 DOI: 10.1016/J.Wneu.2016.09.059  0.309
2016 Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. Neuro-Oncology. PMID 27571885 DOI: 10.1093/Neuonc/Now176  0.357
2016 Duncan VE, Nabors LB, Warren PP, Conry RM, Willey CD, Perry A, Riley KO, Hackney JR. Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary Adenoma. International Journal of Surgical Pathology. PMID 27422470 DOI: 10.1177/1066896916658955  0.384
2016 Perry A. WHO's arrived in 2016! An updated weather forecast for integrated brain tumor diagnosis. Brain Tumor Pathology. PMID 27295314 DOI: 10.1007/S10014-016-0266-4  0.349
2016 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 131: 803-20. PMID 27157931 DOI: 10.1007/S00401-016-1545-1  0.451
2016 Olar A, Lapadat R, Davidson CJ, Stein TD, Dahiya S, Perry A, Gheorghe G. Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature. Clinical Neuropathology. PMID 27125868 DOI: 10.5414/Np300949  0.336
2016 Perry A, Wesseling P. Histologic classification of gliomas. Handbook of Clinical Neurology. 134: 71-95. PMID 26948349 DOI: 10.1016/B978-0-12-802997-8.00005-0  0.429
2016 Schwetye KE, Joseph NM, Al-Kateb H, Rich KM, Schmidt RE, Perry A, Gutmann DH, Dahiya S. Gliosarcomas lack BRAF(V600E) mutation, but a subset exhibit β-catenin nuclear localization. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 26932501 DOI: 10.1111/Neup.12293  0.315
2016 Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, ... ... Perry A, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 164: 1060-1072. PMID 26919435 DOI: 10.1016/J.Cell.2016.01.015  0.442
2016 Röhrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, Becker A, Weis J, Mawrin C, Mittelbronn M, Perry A, et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathologica. PMID 26857854 DOI: 10.1007/S00401-016-1540-6  0.404
2016 Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, ... ... Perry A, et al. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathologica. PMID 26810070 DOI: 10.1007/S00401-016-1539-Z  0.411
2016 Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C. Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 75: 44-52. PMID 26705409 DOI: 10.1093/Jnen/Nlv006  0.439
2016 Wahl MT, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan D, Costello JF, Dayal M, Butowski NA, Clarke JL, Prados M, Berger MS, Nelson SJ, Chang SM. Adjuvant temozolomide for low grade gliomas: Molecular and radiographic correlates of treatment response in a phase II clinical trial. Journal of Clinical Oncology. 34: 2002-2002. DOI: 10.1200/Jco.2016.34.15_Suppl.2002  0.326
2016 Kline C, Solomon D, Perry A, Bastian B, Joseph N, Phillips J, Tihan T, Yeh I, Van Ziffle J, Grenert J, Bollen A, Mueller S, Banerjee A, Gupta N, Raffel C, et al. TB-02UPFRONT, REAL-TIME TUMOR AND GERMLINE SEQUENCING OF PEDIATRIC BRAIN TUMOR PATIENTS: THE UCSF EXPERIENCE Neuro-Oncology. 18: iii169.2-iii169. DOI: 10.1093/Neuonc/Now084.02  0.371
2016 Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Vogel H, Giangaspero F, Antonelli M, Riemenschneider M, Bernardo MC, Giannini C, Din NU, Perry A, Keyvani K, et al. AT-10ATYPICAL TERATOID RHABDOID TUMORS AND POORLY DIFFERENTIATED CHORDOMAS: DISTINCT MOLECULAR ENTITIES WITH SMARCB1/INI1 LOSS AND DISMAL PROGNOSIS Neuro-Oncology. 18: iii3.1-iii3. DOI: 10.1093/Neuonc/Now065.09  0.341
2015 Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Brain Pathology (Zurich, Switzerland). PMID 26517431 DOI: 10.1111/Bpa.12336  0.399
2015 Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, et al. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncology. PMID 26493095 DOI: 10.1093/Neuonc/Nov247  0.312
2015 Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL, Nolop KB, Hsu HH, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncology. PMID 26449250 DOI: 10.1093/Neuonc/Nov245  0.33
2015 Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, et al. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75: 3065-76. PMID 26239477 DOI: 10.1158/0008-5472.Can-14-3307  0.321
2015 Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E, Scharnhorst DW, Samuel D, Ellison DW, Perry A. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas - Same Entity or First Cousins? Brain Pathology (Zurich, Switzerland). PMID 26238627 DOI: 10.1111/Bpa.12295  0.412
2015 Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ. Molecular Analysis of Pediatric Oligodendrogliomas Highlights Genetic Differences with Adult Counterparts and Other Pediatric Gliomas. Brain Pathology (Zurich, Switzerland). PMID 26206478 DOI: 10.1111/Bpa.12291  0.326
2015 Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathologica. 130: 441-3. PMID 26195322 DOI: 10.1007/S00401-015-1459-3  0.385
2015 Cimino PJ, Gonzalez-Cuyar LF, Perry A, Dahiya S. Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. Neurosurgery. 77: 621-8. PMID 26125673 DOI: 10.1227/Neu.0000000000000877  0.417
2015 Liverman C, Mafra M, Chuang SS, Shivane A, Chakrabarty A, Highley R, Hilton DA, Byrne NP, Wesseling P, Perry A. A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern. Acta Neuropathologica. PMID 26106026 DOI: 10.1007/S00401-015-1456-6  0.391
2015 Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, ... ... Perry A, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. The New England Journal of Medicine. 372: 2499-508. PMID 26061753 DOI: 10.1056/Nejmoa1407279  0.408
2015 Wesseling P, van den Bent M, Perry A. Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathologica. 129: 809-27. PMID 25943885 DOI: 10.1007/S00401-015-1424-1  0.374
2015 Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X, McDonald S, DeSchryver K, Duncavage EJ, Walrath J, Reilly KM, Abel HJ, Pekmezci M, Perry A, Ley TJ, et al. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25925892 DOI: 10.1158/1078-0432.Ccr-14-3049  0.365
2015 Hansen JM, Larsen VA, Scheie D, Perry A, Skjøth-Rasmussen J. Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features. Cephalalgia : An International Journal of Headache. PMID 25900984 DOI: 10.1177/0333102415583988  0.368
2015 Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM, Phillips JJ, Vogel H, Wiencke JK, Wrensch MR, Walsh KM, Perry A. CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas. Journal of Neuropathology and Experimental Neurology. 74: 442-52. PMID 25853694 DOI: 10.1097/Nen.0000000000000188  0.372
2015 Pekmezci M, Perry A. Practical molecular pathologic diagnosis of infiltrating gliomas. Surgical Pathology Clinics. 8: 49-61. PMID 25783821 DOI: 10.1016/J.Path.2014.10.004  0.337
2015 Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, Meyer J, Schrimpf D, Kool M, Northcott PA, Zheludkova O, Milde T, Witt O, Kulozik AE, Reifenberger G, ... ... Perry A, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathologica. 129: 669-78. PMID 25752754 DOI: 10.1007/S00401-015-1405-4  0.457
2015 Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathologica. 129: 609-10. PMID 25720745 DOI: 10.1007/S00401-015-1400-9  0.425
2015 Perry AW, Sosin M, Weissler JM, Chiaffarano JM, Barnard NJ. Multiple glomus tumors presenting as an aesthetic abnormality. Aesthetic Plastic Surgery. 39: 236-9. PMID 25673571 DOI: 10.1007/s00266-015-0453-4  0.318
2015 Ud Din N, Pekmezci M, Javed G, Horvai AE, Ahmad Z, Faheem M, Navarro AL, López-Terrada D, Perry A. Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical course. Human Pathology. 46: 153-8. PMID 25454478 DOI: 10.1016/J.Humpath.2014.09.015  0.426
2015 Alexandrescu S, Orengo JP, Toossi S, Perry A, Treseler P, Hess C, Margeta M. CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 35: 170-4. PMID 25378202 DOI: 10.1111/Neup.12175  0.337
2015 Pekmezci M, Reuss DE, Hirbe AC, Dahiya S, Gutmann DH, von Deimling A, Horvai AE, Perry A. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 187-200. PMID 25189642 DOI: 10.1038/Modpathol.2014.109  0.399
2015 Walsh K, Pekmezci M, Decker P, Hansen H, Sicotte H, Rice T, Kollmeyer T, McCoy L, Sarkar G, Perry A, Giannini C, Tihan T, Berger M, Molinaro A, Wiemels J, et al. EPID-31ATRX AND TERT ASSAYS PROVIDE NON-REDUNDANT INFORMATION IN ADULT GLIOMA PATIENTS: INCORPORATING TELOMERE MARKERS INTO NEUROPATHOLOGY PRACTICE Neuro-Oncology. 17: v85.1-v85. DOI: 10.1093/Neuonc/Nov213.31  0.422
2015 Ohba S, Mukherjee J, Johannessen TA, Hirose Y, Chow T, Marshall R, Walsh K, Perry A, Phillips J, Ronen S, Pieper R. CBIO-32MUTANT IDH EXPRESSION DRIVES hTERT REACTIVATION AS PART OF THE CELLULAR TRANSFORMATION PROCESS Neuro-Oncology. 17: v61.3-v61. DOI: 10.1093/Neuonc/Nov209.32  0.301
2015 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips J, Sullivan L, Martinez D, Perry A, Lewis P, Thompson C, Judkins A. HG-07 * DETECTION OF K27M MUTANT PEDIATRIC GLIOBLASTOMAS BY IMMUNOHISTOCHEMISTRY Neuro-Oncology. 17: iii12-iii12. DOI: 10.1093/Neuonc/Nov061.44  0.416
2015 Schniederjan MJ, Rodriguez FJ, Nicolaides T, Tihan T, Burger PC, Perry A. GE-03 * HIGH RATE OF CONCURRENT BRAF-KIAA1549 GENE FUSION AND 1p DELETION IN DISSEMINATED OLIGODENDROGLIAL-LIKE LEPTOMENINGEAL TUMORS Neuro-Oncology. 17: iii7-iii7. DOI: 10.1093/Neuonc/Nov061.27  0.435
2014 Hainfellner J, Louis DN, Perry A, Wesseling P. Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171. Brain Pathology (Zurich, Switzerland). 24: 671-2. PMID 25345897 DOI: 10.1111/Bpa.12187  0.32
2014 Pekmezci M, Perry A. Genetic markers in adult high-grade gliomas. Seminars in Radiation Oncology. 24: 235-9. PMID 25219807 DOI: 10.1016/J.Semradonc.2014.06.005  0.344
2014 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathologica. 128: 743-53. PMID 25200322 DOI: 10.1007/S00401-014-1338-3  0.401
2014 Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, et al. International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathology (Zurich, Switzerland). 24: 429-35. PMID 24990071 DOI: 10.1111/Bpa.12171  0.411
2014 Ali S, Joseph NM, Perry A, Barajas RF, Cha S. Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant. Journal of Neuro-Oncology. 119: 353-60. PMID 24893732 DOI: 10.1007/S11060-014-1485-3  0.345
2014 Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Perry A, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/S00401-014-1291-1  0.424
2014 de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park SH, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, ... Perry A, et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathologica. 128: 111-22. PMID 24839956 DOI: 10.1007/S00401-014-1285-Z  0.32
2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Perry A, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/J.Ccr.2014.02.004  0.319
2014 Pekmezci M, Vlodavsky E, Perry A. Previously unrecognized pattern of central nervous system hemangiopericytoma with pseudoglandular spaces. Clinical Neuropathology. 33: 186-9. PMID 24618071 DOI: 10.5414/Np300721  0.38
2014 Sabha N, Knobbe CB, Maganti M, Al Omar S, Bernstein M, Cairns R, Çako B, von Deimling A, Capper D, Mak TW, Kiehl TR, Carvalho P, Garrett E, Perry A, Zadeh G, et al. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Neuro-Oncology. 16: 914-23. PMID 24470545 DOI: 10.1093/Neuonc/Not299  0.348
2014 Lal A, Dahiya S, Gonzales M, Hiniker A, Prayson R, Kleinschmidt-DeMasters BK, Perry A. IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases. Brain Pathology (Zurich, Switzerland). 24: 352-9. PMID 24467316 DOI: 10.1111/Bpa.12128  0.3
2014 Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro-Oncology. 16: 466-7. PMID 24366910 DOI: 10.1093/Neuonc/Not248  0.414
2014 Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DT, Remke M, Northcott P, Perry A, Picard D, Rosenblum M, Antonelli M, Aronica E, Schüller U, Hasselblatt M, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathologica. 128: 279-89. PMID 24337497 DOI: 10.1007/S00401-013-1228-0  0.455
2014 Dahiya S, Emnett RJ, Haydon DH, Leonard JR, Phillips JJ, Perry A, Gutmann DH. BRAF-V600E mutation in pediatric and adult glioblastoma. Neuro-Oncology. 16: 318-9. PMID 24311634 DOI: 10.1093/Neuonc/Not146  0.419
2014 Krishnan C, Vogel H, Perry A. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature. Human Pathology. 45: 185-8. PMID 24034858 DOI: 10.1016/J.Humpath.2013.07.039  0.449
2014 Butowski NA, Colman H, De Groot JF, Omuro AMP, Nayak L, Cloughesy TF, Marimuthu A, Perry A, Phillips JJ, West B, Prados M, Nolop KB, Hsu HH, Ligon KL. A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma. Journal of Clinical Oncology. 32: 2023-2023. DOI: 10.1200/Jco.2014.32.15_Suppl.2023  0.36
2014 Wrensch M, Walsh KM, Smirnov IV, Rice T, Hansen HM, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Perry A, Marshall R, Pekmezci M, Zheng S, Wiemels JL, Tihan T, et al. SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) ASSOCIATED WITH GLIOMA SURVIVAL Neuro-Oncology. 16: iii2-iii2. DOI: 10.1093/Neuonc/Nou206.7  0.328
2014 Jenkins RB, Decker P, Kosel M, Eckel-Passow J, Walsh KM, Smirnov IV, Caron A, Kollmeyer T, Rice T, Hansen HM, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Marshall R, ... ... Perry A, et al. MUTATION-BASED MOLECULAR GLIOMA CLASSIFICATION: PREVALENCE AND ASSOCIATION WITH GERMLINE RISK SNPS Neuro-Oncology. 16: iii1-iii1. DOI: 10.1093/Neuonc/Nou206.3  0.333
2014 Perry A, Reis GF, Pekmezci M, Hansen HM, Marshall RE, Rice T, Wiencke JF, Wrensch MR, Walsh KM, Perry A. CDKN2A LOSS IS ASSOCIATED WITH SHORTENED SURVIVAL IN INFILTRATING ASTROCYTOMAS BUT NOT OLIGODENDROGLIOMAS OR MIXED OLIGOASTROCYTOMAS Neuro-Oncology. 16: iii1-iii22. DOI: 10.1093/Neuonc/Nou206.22  0.394
2014 Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Perry A, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071  0.305
2013 Cykowski MD, Allen RA, Kanaly AC, Fung KM, Marshall R, Perry A, Stolzenberg ED, Dunn ST. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features. Journal of Neuro-Oncology. 115: 477-86. PMID 24057326 DOI: 10.1007/S11060-013-1249-5  0.39
2013 Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1425-32. PMID 23765250 DOI: 10.1038/Modpathol.2013.90  0.393
2013 Pekmezci M, Perry A. Neuropathology of brain metastases. Surgical Neurology International. 4: S245-55. PMID 23717796 DOI: 10.4103/2152-7806.111302  0.424
2013 Reis GF, Bloomer MM, Perry A, Phillips JJ, Grenert JP, Karnezis AN, Tihan T. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1279-87. PMID 23702730 DOI: 10.1038/Modpathol.2013.79  0.326
2013 Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB. Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. Journal of Neuropathology and Experimental Neurology. 72: 298-306. PMID 23481705 DOI: 10.1097/Nen.0B013E3182898113  0.39
2013 Hiniker A, Lee HS, Chang S, Berger M, Perry A. Cortical ependymoma with unusual histologic features. Clinical Neuropathology. 32: 318-23. PMID 23458270 DOI: 10.5414/Np300593  0.339
2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, ... ... Perry A, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043  0.394
2013 Hiniker A, Hagenkord JM, Powers MP, Aghi MK, Prados MD, Perry A. Gliosarcoma arising from an oligodendroglioma (oligosarcoma). Clinical Neuropathology. 32: 165-70. PMID 23254140 DOI: 10.5414/Np300577  0.435
2013 Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, et al. PDGFRA gain in low-grade diffuse gliomas. Journal of Neuropathology and Experimental Neurology. 72: 61-6. PMID 23242283 DOI: 10.1097/Nen.0B013E31827C4B5B  0.377
2013 Poole Perry LJ, Jakobiec FA, Zakka FR, Reichel E, Herwig MC, Perry A, Brat DJ, Grossniklaus HE. Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. American Journal of Ophthalmology. 155: 593-608.e1. PMID 23219067 DOI: 10.1016/J.Ajo.2012.09.002  0.393
2013 Yeo YH, Byrne NP, Counelis GJ, Perry A. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss. Clinical Neuropathology. 32: 159-64. PMID 23196000 DOI: 10.5414/Np300564  0.444
2013 Joseph NM, Phillips J, Dahiya S, M Felicella M, Tihan T, Brat DJ, Perry A. Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 315-26. PMID 23041832 DOI: 10.1038/Modpathol.2012.173  0.356
2013 Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathology (Zurich, Switzerland). 23: 178-91. PMID 22966790 DOI: 10.1111/J.1750-3639.2012.00631.X  0.396
2013 Widemann BC, Reinke DK, Helman LJ, Ludwig JA, Schuetze S, Staddon AP, Milhem MM, Rushing DA, Moertel CL, Goldman S, Livingston MB, Wagner LM, Rodler ET, Dombi E, Perry A, et al. SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs). Journal of Clinical Oncology. 31: 10522-10522. DOI: 10.1200/Jco.2013.31.15_Suppl.10522  0.319
2013 Haas-Kogan D, Phillips JJ, Molinaro A, Wahl M, Mueller S, Weiss WA, Lupo JM, Berger MS, Prados MD, Butowski N, Clarke J, Perry A, Nelson SJ, Chang S. Abstract 3520: Imaging parameters and molecular correlates as predictive markers of treatment response to mTOR inhibition in adults with recurrent low-grade gliomas. Cancer Research. 73: 3520-3520. DOI: 10.1158/1538-7445.Am2013-3520  0.356
2013 Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim Y, Mariani L, Vital A, Perry A, et al. Abstract 2406: Intra-tumoral heterogeneity of PDGFRA / MET gain in WHO grade II diffuse astrocytomas. Cancer Research. 73: 2406-2406. DOI: 10.1158/1538-7445.Am2013-2406  0.372
2012 Korshunov A, Ryzhova M, Jones DT, Northcott PA, van Sluis P, Volckmann R, Koster J, Versteeg R, Cowdrey C, Perry A, Picard D, Rosenblum M, Giangaspero F, Aronica E, Schüller U, et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathologica. 124: 875-81. PMID 23161096 DOI: 10.1007/S00401-012-1068-3  0.427
2012 Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathologica. 124: 627-41. PMID 22941225 DOI: 10.1007/S00401-012-1037-X  0.435
2012 Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, Perry A. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery. 71: 951-61. PMID 22843130 DOI: 10.1227/Neu.0B013E31826Adf65  0.405
2012 Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathologica. 124: 449-51. PMID 22772980 DOI: 10.1007/S00401-012-1011-7  0.305
2012 Felicella MM, Hagenkord JM, Kash SF, Powers MP, Berger MS, Perry A. A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping. Clinical Neuropathology. 31: 210-5. PMID 22720694 DOI: 10.5414/Np300484  0.447
2012 Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, Grimmer MR, Lau J, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell. 21: 601-13. PMID 22624711 DOI: 10.1016/J.Ccr.2012.04.012  0.368
2012 Huillard E, Hashizume R, Phillips JJ, Griveau A, Ihrie RA, Aoki Y, Nicolaides T, Perry A, Waldman T, McMahon M, Weiss WA, Petritsch C, James CD, Rowitch DH. Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy. Proceedings of the National Academy of Sciences of the United States of America. 109: 8710-5. PMID 22586120 DOI: 10.1073/Pnas.1117255109  0.307
2012 Bien-Willner GA, López-Terrada D, Bhattacharjee MB, Patel KU, Stankiewicz P, Lupski JR, Pfeifer JD, Perry A. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement. Neuro-Oncology. 14: 831-40. PMID 22573308 DOI: 10.1093/Neuonc/Nos086  0.391
2012 Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Brain Pathology (Zurich, Switzerland). 22: 834-40. PMID 22568401 DOI: 10.1111/J.1750-3639.2012.00601.X  0.334
2012 Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathologica. 123: 295-319. PMID 22327363 DOI: 10.1007/S00401-012-0954-Z  0.385
2012 Barajas RF, Perry A, Sughrue M, Aghi M, Cha S. Intracranial subdural osteoma: a rare benign tumor that can be differentiated from other calcified intracranial lesions utilizing MR imaging. Journal of Neuroradiology. Journal De Neuroradiologie. 39: 263-6. PMID 22197691 DOI: 10.1016/J.Neurad.2011.11.003  0.34
2012 Goldhoff P, Clarke J, Smirnov I, Berger MS, Prados MD, James CD, Perry A, Phillips JJ. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype. Journal of Neuropathology and Experimental Neurology. 71: 83-9. PMID 22157621 DOI: 10.1097/Nen.0B013E31823Fe8F1  0.429
2012 Creach KM, Rubin JB, Leonard JR, Limbrick DD, Smyth MD, Dacey R, Rich KM, Dowling JL, Grubb RL, Linette GP, King AA, Michalski JM, Park TS, Perry A, Simpson JR, et al. Oligodendrogliomas in children. Journal of Neuro-Oncology. 106: 377-82. PMID 21842314 DOI: 10.1007/S11060-011-0674-6  0.365
2011 Han SJ, Clark AJ, Ivan ME, Parsa AT, Perry A. Pathology of pineal parenchymal tumors. Neurosurgery Clinics of North America. 22: 335-40, vii. PMID 21801981 DOI: 10.1016/J.Nec.2011.05.006  0.416
2011 Deshmukh H, Yu J, Shaik J, MacDonald TJ, Perry A, Payton JE, Gutmann DH, Watson MA, Nagarajan R. Identification of transcriptional regulatory networks specific to pilocytic astrocytoma. Bmc Medical Genomics. 4: 57. PMID 21745356 DOI: 10.1186/1755-8794-4-57  0.35
2011 Remke M, Hielscher T, Northcott PA, Witt H, Ryzhova M, Wittmann A, Benner A, von Deimling A, Scheurlen W, Perry A, Croul S, Kulozik AE, Lichter P, Taylor MD, Pfister SM, et al. Adult medulloblastoma comprises three major molecular variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2717-23. PMID 21632505 DOI: 10.1200/Jco.2011.34.9373  0.392
2011 Patil S, Scheithauer BW, Strom RG, Mafra M, Chicoine MR, Perry A. Malignant meningiomas with epithelial (adenocarcinoma-like) metaplasia: a study of 3 cases. Neurosurgery. 69: 884-92. PMID 21558975 DOI: 10.1227/Neu.0B013E318222Dc6F  0.378
2011 Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, ... ... Perry A, et al. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1924-34. PMID 21325289 DOI: 10.1158/1078-0432.Ccr-10-1551  0.387
2011 Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathology (Zurich, Switzerland). 21: 564-74. PMID 21314850 DOI: 10.1111/J.1750-3639.2011.00480.X  0.39
2011 Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica. 121: 381-96. PMID 21267586 DOI: 10.1007/S00401-011-0800-8  0.433
2011 Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH. Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. Journal of Neuropathology and Experimental Neurology. 70: 1-12. PMID 21157382 DOI: 10.1097/Nen.0B013E3182018F1C  0.33
2011 Horbinski C, Miller CR, Perry A. Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade. Brain Pathology (Zurich, Switzerland). 21: 57-73. PMID 21129060 DOI: 10.1111/J.1750-3639.2010.00453.X  0.451
2011 Swartling FJ, Persson AI, Lau J, Northcott PA, Grimmer MR, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA. Abstract 3451: Interactions between N-myc and Sox9 promote medulloblastoma and determine cell fate decisions in cerebellar neural stem cells Cancer Research. 71: 3451-3451. DOI: 10.1158/1538-7445.Am2011-3451  0.333
2010 Johnson MW, Eberhart CG, Perry A, Tihan T, Cohen KJ, Rosenblum MK, Rais-Bahrami S, Goldthwaite P, Burger PC. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. The American Journal of Surgical Pathology. 34: 1783-91. PMID 21107083 DOI: 10.1097/Pas.0B013E3181Fd66C3  0.438
2010 Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL. Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma. American Journal of Clinical Pathology. 134: 880-5. PMID 21088150 DOI: 10.1309/Ajcpk6Qhnnoemjim  0.344
2010 Dahiya S, Perry A. Pineal tumors. Advances in Anatomic Pathology. 17: 419-27. PMID 20966647 DOI: 10.1097/PAP.0b013e3181f895a4  0.31
2010 Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. Journal of Neuro-Oncology. 99: 379-91. PMID 20809251 DOI: 10.1007/S11060-010-0342-2  0.416
2010 Lusis EA, Travers S, Jost SC, Perry A. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases. Neurosurgery. 67: 811-7; discussion 81. PMID 20657316 DOI: 10.1227/01.Neu.0000375513.12925.5C  0.399
2010 Lwu S, Starreveld YP, Branson J, Perry A. Anaplastic meningioma arising from a radiologically diagnosed arachnoid cyst: Case report Neurosurgery. 67. PMID 20559070 DOI: 10.1227/01.Neu.0000370013.55369.92  0.37
2010 Perry A, Burton SS, Fuller GN, Robinson CA, Palmer CA, Resch L, Bigio EH, Gujrati M, Rosenblum MK. Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathologica. 120: 237-52. PMID 20464403 DOI: 10.1007/S00401-010-0695-9  0.386
2010 Shah MN, Leonard JR, Perry A. Rosette-forming glioneuronal tumors of the posterior fossa: Report of 6 cases Journal of Neurosurgery: Pediatrics. 5: 98-103. PMID 20043744 DOI: 10.3171/2009.7.Peds09113  0.437
2010 Mannan AA, Rifaat AA, Kahvic M, Kapila K, Mallik M, Grover VK, Bharati C, Perry A. Proximal-type epithelioid sarcoma in the groin presenting as a diagnostic dilemma. Pathology Oncology Research : Por. 16: 181-8. PMID 19757197 DOI: 10.1007/S12253-009-9203-8  0.437
2010 Behdad A, Perry A. Central nervous system primitive neuroectodermal tumors: A clinicopathologic and genetic study of 33 cases Brain Pathology. 20: 441-450. PMID 19725831 DOI: 10.1111/J.1750-3639.2009.00314.X  0.454
2009 Darken RS, Bogitch R, Leonard J, Perry A, McKinstry RC, Gutmann DH, Rubin JB. Brainstem glioma presenting as pruritus in children with neurofibromatosis-1. Journal of Pediatric Hematology/Oncology. 31: 972-6. PMID 19935099 DOI: 10.1097/Mph.0B013E3181B8701F  0.371
2009 Lennerz JK, Perry A, Dehner LP, Pfeifer JD, Lind AC. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma. The British Journal of Dermatology. 161: 925-9. PMID 19438452 DOI: 10.1111/J.1365-2133.2009.09200.X  0.32
2009 Chernock RD, Perry A, Pfeifer JD, Holden JA, Lewis JS. Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu expression. Head & Neck. 31: 919-27. PMID 19283847 DOI: 10.1002/Hed.21061  0.302
2009 Tibbetts KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR. Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathologica. 117: 657-65. PMID 19271226 DOI: 10.1007/S00401-009-0506-3  0.394
2009 Ray WZ, Blackburn SL, Casavilca-Zambrano S, Barrionuevo C, Orrego JE, Heinicke H, Dowling JL, Perry A. Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. Journal of Neuro-Oncology. 94: 283-92. PMID 19267228 DOI: 10.1007/S11060-009-9849-9  0.436
2009 Shamji MF, Benoit BG, Perry A, Jansen GH. Giant cell ependymoma of the thoracic spine: pathology case report. Neurosurgery. 64: E566-7; discussion E. PMID 19240583 DOI: 10.1227/01.Neu.0000338428.01654.A4  0.352
2009 Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. The American Journal of Surgical Pathology. 33: 835-43. PMID 19092631 DOI: 10.1097/Pas.0B013E318190Cf5B  0.383
2009 Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathology (Zurich, Switzerland). 19: 81-90. PMID 18452568 DOI: 10.1111/J.1750-3639.2008.00167.X  0.491
2008 Goldhoff P, Warrington NM, Limbrick DD, Hope A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB. Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7717-25. PMID 19047098 DOI: 10.1158/1078-0432.Ccr-08-0827  0.37
2008 Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, Jenkins RB, Scheithauer BW, Anant S, Jenkins S, Eberhart CG, Sarkaria JN, Gutmann DH. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes. Journal of Neuropathology and Experimental Neurology. 67: 1194-204. PMID 19018242 DOI: 10.1097/Nen.0B013E31818Fbe1E  0.339
2008 Trembath D, Miller CR, Perry A. Gray zones in brain tumor classification: evolving concepts. Advances in Anatomic Pathology. 15: 287-97. PMID 18724102 DOI: 10.1097/Pap.0B013E3181836A03  0.494
2008 Tepel M, Roerig P, Wolter M, Gutmann DH, Perry A, Reifenberger G, Riemenschneider MJ. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. International Journal of Cancer. 123: 2080-6. PMID 18709645 DOI: 10.1002/Ijc.23705  0.39
2008 Frei-Jones M, McKinstry RC, Perry A, Leonard JR, Park TS, Rubin JB. Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. Journal of Neurosurgery. Pediatrics. 2: 125-9. PMID 18671617 DOI: 10.3171/Ped/2008/2/8/125  0.325
2008 Patil S, Perry A, Maccollin M, Dong S, Betensky RA, Yeh TH, Gutmann DH, Stemmer-Rachamimov AO. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathology (Zurich, Switzerland). 18: 517-9. PMID 18422762 DOI: 10.1111/J.1750-3639.2008.00155.X  0.412
2008 Deshmukh H, Yeh TH, Yu J, Sharma MK, Perry A, Leonard JR, Watson MA, Gutmann DH, Nagarajan R. High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene. 27: 4745-51. PMID 18408760 DOI: 10.1038/Onc.2008.110  0.406
2008 Rodriguez FJ, Scheithauer BW, Perry A, Oliveira AM, Jenkins RB, Oviedo A, Mork SJ, Palmer CA, Burger PC. Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study. The American Journal of Surgical Pathology. 32: 699-709. PMID 18347506 DOI: 10.1097/Pas.0B013E318158234E  0.354
2008 Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. Journal of Neuropathology and Experimental Neurology. 67: 240-9. PMID 18344915 DOI: 10.1097/Nen.0B013E318165Eb75  0.402
2008 Polydorides AD, Perry A, Edgar MA. Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis. Journal of Neuro-Oncology. 88: 193-7. PMID 18317693 DOI: 10.1007/S11060-008-9548-Y  0.427
2008 Hegedus B, Banerjee D, Yeh TH, Rothermich S, Perry A, Rubin JB, Garbow JR, Gutmann DH. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. Cancer Research. 68: 1520-8. PMID 18316617 DOI: 10.1158/0008-5472.Can-07-5916  0.389
2008 Dunham C, Hussong J, Seiff M, Pfeifer J, Perry A. Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes. The American Journal of Surgical Pathology. 32: 478-84. PMID 18300800 DOI: 10.1097/Pas.0B013E3181453451  0.335
2008 Perry A. A GBM by any other name? Brain Pathology. 18. DOI: 10.1111/J.1750-3639.2008.00178.X  0.314
2007 Wagner LM, Garrett JK, Ballard ET, Hill DA, Perry A, Biegel JA, Collins MH. Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 10: 409-15. PMID 17929989 DOI: 10.2350/06-08-0155.1  0.433
2007 Wippold FJ, Lubner M, Perrin RJ, Lämmle M, Perry A. Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns. Ajnr. American Journal of Neuroradiology. 28: 1633-8. PMID 17893219 DOI: 10.3174/Ajnr.A0682  0.317
2007 Warrington NM, Woerner BM, Daginakatte GC, Dasgupta B, Perry A, Gutmann DH, Rubin JB. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1. Cancer Research. 67: 8588-95. PMID 17875698 DOI: 10.1158/0008-5472.Can-06-2220  0.319
2007 Spinner RJ, Scheithauer BW, Perry A, Amrami KK, Emnett R, Gutmann DH. Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report. Journal of Neurosurgery. 107: 435-9. PMID 17695403 DOI: 10.3171/Jns-07/08/0435  0.383
2007 Kazmi SA, Perry A, Pressey JG, Wellons JC, Hammers Y, Palmer CA. Primary Ewing sarcoma of the brain: a case report and literature review. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 16: 108-11. PMID 17525681 DOI: 10.1097/Pdm.0B013E3180375541  0.449
2007 Miller CR, Perry A. Glioblastoma. Archives of Pathology & Laboratory Medicine. 131: 397-406. PMID 17516742 DOI: 10.1043/1543-2165(2007)131[397:G]2.0.Co;2  0.472
2007 Sanati S, Lu DW, Schmidt E, Perry A, Dehner LP, Pfeifer JD. Cytologic diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis. Cancer. 111: 192-9. PMID 17487851 DOI: 10.1002/Cncr.22692  0.434
2007 Brat DJ, Shehata BM, Castellano-Sanchez AA, Hawkins C, Yost RB, Greco C, Mazewski C, Janss A, Ohgaki H, Perry A. Congenital glioblastoma: a clinicopathologic and genetic analysis. Brain Pathology (Zurich, Switzerland). 17: 276-81. PMID 17465990 DOI: 10.1111/J.1750-3639.2007.00071.X  0.442
2007 Chacko G, Chacko AG, Dunham CP, Judkins AR, Biegel JA, Perry A. Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma. Journal of Neuro-Oncology. 84: 217-22. PMID 17431546 DOI: 10.1007/S11060-007-9361-Z  0.447
2007 Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH. Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. Journal of Neuro-Oncology. 84: 49-55. PMID 17377740 DOI: 10.1007/S11060-007-9339-X  0.434
2007 Dunham C, Sugo E, Tobias V, Wills E, Perry A. Embryonal tumor with abundant neuropil and true rosettes (ETANTR): report of a case with prominent neurocytic differentiation. Journal of Neuro-Oncology. 84: 91-8. PMID 17332950 DOI: 10.1007/S11060-007-9346-Y  0.441
2007 Martin DT, Gendron RL, Jarzembowski JA, Perry A, Collins MH, Pushpanathan C, Miskiewicz E, Castle VP, Paradis H. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors Clinical Cancer Research. 13: 1480-1487. PMID 17332292 DOI: 10.1158/1078-0432.Ccr-06-1716  0.383
2007 Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1466-71. PMID 17332290 DOI: 10.1158/1078-0432.Ccr-06-2401  0.314
2007 Rajaram V, Knezevich S, Bove KE, Perry A, Pfeifer JD. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation. Genes, Chromosomes & Cancer. 46: 508-13. PMID 17311249 DOI: 10.1002/Gcc.20437  0.34
2007 Aldape K, Burger PC, Perry A. Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Archives of Pathology & Laboratory Medicine. 131: 242-51. PMID 17284109 DOI: 10.1043/1543-2165(2007)131[242:Caoqla]2.0.Co;2  0.351
2007 Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Research. 67: 890-900. PMID 17283119 DOI: 10.1158/0008-5472.Can-06-0973  0.404
2007 Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Research. 67: 651-8. PMID 17234775 DOI: 10.1158/0008-5472.Can-06-2762  0.377
2007 Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. The Lancet. Neurology. 5: 1045-54. PMID 17110285 DOI: 10.1016/S1474-4422(06)70625-1  0.378
2007 Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathologica. 113: 313-24. PMID 17061076 DOI: 10.1007/S00401-006-0153-X  0.346
2007 Rodriguez FJ, Scheithauer BW, Burger PC, Perry A, Mork SJ. Gliosarcoma arising in ependymomas ("ependymosarcoma"): a clinicopathologic study Journal of Neuropathology and Experimental Neurology. 66: 446. DOI: 10.1097/01.Jnen.0000268921.27139.44  0.332
2007 Miller CR, Haddix T, Dunham CP, Perry A. Clinical significance of prospective molecular genetic analysis of glial neoplasms: the Washington University FISH laboratory experience Journal of Neuropathology and Experimental Neurology. 66: 426. DOI: 10.1097/01.Jnen.0000268836.67111.A3  0.372
2007 Rodriguez FJ, Scheithauer BW, Burger PC, Perry A, Mork SJ. Gliosarcoma arising in ependymomas ("ependymosarcoma"): a clinicopathologic study The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A395-A  0.332
2007 Miller CR, Haddix T, Dunham CP, Perry A. Clinical significance of prospective molecular genetic analysis of glial neoplasms: The Washington University FISH Laboratory experience The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A26-A  0.372
2007 Chicoine M, Jost S, Custer P, Perry A, Wippold F, Simpson J. Spheno-Orbital Meningiomas: Radiographic Findings, Surgical Management, Histopathology, and Clinical Outcomes Skull Base. 16. DOI: 10.1055/S-2006-958313  0.383
2006 Miller CR, Dunham CP, Scheithauer BW, Perry A. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5419-26. PMID 17135643 DOI: 10.1200/Jco.2006.08.1497  0.456
2006 Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology. 67: 1509-12. PMID 17060590 DOI: 10.1212/01.Wnl.0000240076.31298.47  0.349
2006 Merrell R, Nabors LB, Perry A, Palmer CA. 1p/19q chromosome deletions in metastatic oligodendroglioma. Journal of Neuro-Oncology. 80: 203-7. PMID 16710746 DOI: 10.1007/S11060-006-9179-0  0.404
2006 Alvarez G, Perry A, Tan BR, Wang HL. Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 942-9. PMID 16648870 DOI: 10.1038/Modpathol.3800608  0.359
2006 Miller SJ, Rangwala F, Williams J, Ackerman P, Kong S, Jegga AG, Kaiser S, Aronow BJ, Frahm S, Kluwe L, Mautner V, Upadhyaya M, Muir D, Wallace M, Hagen J, ... ... Perry A, et al. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Research. 66: 2584-91. PMID 16510576 DOI: 10.1158/0008-5472.Can-05-3330  0.337
2006 Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathologica. 111: 197-212. PMID 16463065 DOI: 10.1007/S00401-005-0023-Y  0.352
2006 Syed S, Rajaram V, Leonard JR, Perry A, Raghavan R. Mixed glioneuronal tumors of the spinal cord in two children. Acta Neuropathologica. 111: 53-5. PMID 16328529 DOI: 10.1007/S00401-005-1089-2  0.425
2006 Perry A, Scheithauer BW. Commentary: Classification and grading of pituitary tumors. Observations of two working neuropathologists. Acta Neuropathologica. 111: 68-70. PMID 16328523 DOI: 10.1007/S00401-005-1098-1  0.386
2006 Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 1-8. PMID 16258512 DOI: 10.1038/Modpathol.3800486  0.384
2006 Bannykh SI, Stolt CC, Kim J, Perry A, Wegner M. Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas. Journal of Neuro-Oncology. 76: 115-27. PMID 16205963 DOI: 10.1007/S11060-005-5533-X  0.405
2006 Miller CR, Dunham CP, Scheithauer BW, Perry A. Significance of necrosis in grading of anaplastic oligodendroglial tumors: A clinicopathological and genetic study of 916 high-grade gliomas Journal of Clinical Oncology. 24: 1502-1502. DOI: 10.1200/Jco.2006.24.18_Suppl.1502  0.425
2006 Perry A. Familial posterior fossa brain tumor syndrome of infancy Advances in Anatomic Pathology. 13: 198-199. DOI: 10.1097/00125480-200607000-00009  0.33
2005 Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Research. 65: 11392-9. PMID 16357147 DOI: 10.1158/0008-5472.Can-05-0847  0.33
2005 Mawrin C, Schulz S, Hellwig-Patyk A, Kirches E, Roessner A, Lendeckel U, Firsching R, Vorwerk CK, Keilhoff G, Dietzmann K, Grimm K, Lindberg G, Gutmann DH, Scheithauer BW, Perry A. Expression and function of somatostatin receptors in peripheral nerve sheath tumors. Journal of Neuropathology and Experimental Neurology. 64: 1080-8. PMID 16319718 DOI: 10.1097/01.Jnen.0000190065.36182.25  0.35
2005 Siami-Namini K, Shuey-Drake R, Wilson D, Francel P, Perry A, Fung KM. A 15-year-old female with progressive myelopathy. Brain Pathology (Zurich, Switzerland). 15: 265-7. PMID 16196395 DOI: 10.1111/J.1750-3639.2005.Tb00531.X  0.374
2005 Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Research. 65: 7121-6. PMID 16103061 DOI: 10.1158/0008-5472.Can-05-0043  0.422
2005 Fuller CE, Perry A. Molecular diagnostics in central nervous system tumors. Advances in Anatomic Pathology. 12: 180-94. PMID 16096380 DOI: 10.1097/01.Pap.0000175117.47918.F7  0.358
2005 Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'Neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5718-27. PMID 16009945 DOI: 10.1200/Jco.2005.17.624  0.38
2005 Lusis EA, Chicoine MR, Perry A. High throughput screening of meningioma biomarkers using a tissue microarray. Journal of Neuro-Oncology. 73: 219-23. PMID 15980972 DOI: 10.1007/S11060-004-5233-Y  0.37
2005 Perry A, Lusis EA, Gutmann DH. Meningothelial hyperplasia: A detailed clinicopathologic, immunohistochemical and genetic study of 11 cases Brain Pathology. 15: 109-115. PMID 15912882 DOI: 10.1111/J.1750-3639.2005.Tb00505.X  0.327
2005 Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of Neuropathology and Experimental Neurology. 64: 391-7. PMID 15892296 DOI: 10.1093/Jnen/64.5.391  0.462
2005 Rogers L, Jensen R, Perry A. Chasing your dural tail: Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas: In regard to DiBiase et al. (Int J Radiat Oncol Biol Phys 2004;60:1515-1519). International Journal of Radiation Oncology, Biology, Physics. 62: 616-8; author reply . PMID 15890610 DOI: 10.1016/J.Ijrobp.2005.02.026  0.3
2005 Perry A, Kurtkaya-Yapicier O, Scheithauer BW, Robinson S, Prayson RA, Kleinschmidt-DeMasters BK, Stemmer-Rachamimov AO, Gutmann DH. Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature. Brain Pathology (Zurich, Switzerland). 15: 55-65. PMID 15779237 DOI: 10.1111/J.1750-3639.2005.Tb00100.X  0.316
2005 Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathology (Zurich, Switzerland). 15: 23-8. PMID 15779233 DOI: 10.1111/J.1750-3639.2005.Tb00096.X  0.448
2005 Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 951-8. PMID 15761491 DOI: 10.1038/Modpathol.3800375  0.433
2005 Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 991-7. PMID 15731777 DOI: 10.1038/Modpathol.3800390  0.355
2005 Covinsky M, Gong S, Rajaram V, Perry A, Pfeifer J. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma. Human Pathology. 36: 74-81. PMID 15712185 DOI: 10.1016/J.Humpath.2004.10.015  0.432
2005 Kloub O, Perry A, Tu PH, Lipper M, Lopes MB. Spindle cell oncocytoma of the adenohypophysis: report of two recurrent cases. The American Journal of Surgical Pathology. 29: 247-53. PMID 15644783 DOI: 10.1097/01.Pas.0000147400.87767.F6  0.318
2005 Bajenaru ML, Garbow JR, Perry A, Hernandez MR, Gutmann DH. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice Annals of Neurology. 57: 119-127. PMID 15622533 DOI: 10.1002/Ana.20337  0.355
2004 Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas Journal of Neuro-Oncology. 70: 183-202. PMID 15674477 DOI: 10.1007/S11060-004-2749-0  0.439
2004 Rajaram V, Brat DJ, Perry A. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. Human Pathology. 35: 1413-8. PMID 15668900 DOI: 10.1016/J.Humpath.2004.07.017  0.327
2004 Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. Journal of Neuropathology and Experimental Neurology. 63: 1015-27. PMID 15535129 DOI: 10.1093/Jnen/63.10.1015  0.384
2004 Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Research. 64: 7787-93. PMID 15520184 DOI: 10.1158/0008-5472.Can-04-1446  0.402
2004 Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann DH. Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathology (Zurich, Switzerland). 14: 297-303. PMID 15446585 DOI: 10.1111/J.1750-3639.2004.Tb00067.X  0.427
2004 Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, et al. Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathology (Zurich, Switzerland). 14: 281-9. PMID 15446583 DOI: 10.1111/J.1750-3639.2004.Tb00065.X  0.388
2004 Fedi M, Anne Mitchell L, Kalnins RM, Gutmann DH, Perry A, Newton M, Brodtmann A, Berkovic SF. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 11: 745-7. PMID 15337138 DOI: 10.1016/J.Jocn.2003.10.017  0.32
2004 Brat DJ, Seiferheld WF, Perry A, Hammond EH, Murray KJ, Schulsinger AR, Mehta MP, Curran WJ. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Neuro-Oncology. 6: 96-103. PMID 15134623 DOI: 10.1215/S1152851703000231  0.335
2004 Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. Journal of Neuropathology and Experimental Neurology. 63: 314-22. PMID 15099021 DOI: 10.1093/Jnen/63.4.314  0.382
2004 Rajaram V, Leuthardt EC, Singh PK, Ojemann JG, Brat DJ, Prayson RA, Perry A. 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 17: 9-14. PMID 14631364 DOI: 10.1038/Modpathol.3800029  0.436
2004 Miller CR, Perry A. CD34 and MAP-2 Immunohistochemistry in the Differential Diagnosis of Epilepsy-Associated Glioneuronal Tumors Advances in Anatomic Pathology. 11: 326-327. DOI: 10.1097/01.Pap.0000146224.33552.F0  0.407
2004 Miller CR, Perry A. Immunohistochemical Differentiation of Hemangioblastoma from Metastatic Clear Cell Renal Carcinoma: An Update Advances in Anatomic Pathology. 11: 325-326. DOI: 10.1097/01.Pap.0000146223.33552.3E  0.328
2003 Fuller CE, Schmidt RE, Roth KA, Burger PC, Scheithauer BW, Banerjee R, Trinkaus K, Lytle R, Perry A. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. Journal of Neuropathology and Experimental Neurology. 62: 1118-28. PMID 14656070 DOI: 10.1093/Jnen/62.11.1118  0.419
2003 Gutmann DH, James CD, Poyhonen M, Louis DN, Ferner R, Guha A, Hariharan S, Viskochil D, Perry A. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology. 61: 1397-400. PMID 14638962 DOI: 10.1212/Wnl.61.10.1397  0.36
2003 Kaufman DL, Heinrich BS, Willett C, Perry A, Finseth F, Sobel RA, MacCollin M. Somatic instability of the NF2 gene in schwannomatosis. Archives of Neurology. 60: 1317-20. PMID 12975302 DOI: 10.1001/Archneur.60.9.1317  0.422
2003 Foster WJ, Fuller CE, Perry A, Harbour JW. Status of the NF1 tumor suppressor locus in uveal melanoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 121: 1311-5. PMID 12963615 DOI: 10.1001/Archopht.121.9.1311  0.397
2003 Perry A, Dehner LP. Meningeal tumors of childhood and infancy. An update and literature review. Brain Pathology (Zurich, Switzerland). 13: 386-408. PMID 12946028 DOI: 10.1111/J.1750-3639.2003.Tb00038.X  0.418
2003 Robb VA, Li W, Gascard P, Perry A, Mohandas N, Gutmann DH. Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis. Neurobiology of Disease. 13: 191-202. PMID 12901833 DOI: 10.1016/S0969-9961(03)00071-8  0.322
2003 Nestor SL, Perry A, Kurtkaya O, Abell-Aleff P, Rosemblat AM, Burger PC, Scheithauer BW. Melanocytic colonization of a meningothelial meningioma: histopathological and ultrastructural findings with immunohistochemical and genetic correlation: case report. Neurosurgery. 53: 211-4; discussion 21. PMID 12823892 DOI: 10.1227/01.Neu.0000068990.79680.F6  0.426
2003 MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS, Perry A, Louis DN. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 60: 1968-74. PMID 12821741 DOI: 10.1212/01.Wnl.0000070184.08740.E0  0.379
2003 Perry A. Pathology of low-grade gliomas: an update of emerging concepts. Neuro-Oncology. 5: 168-78. PMID 12816723 DOI: 10.1215/S1152851702000443  0.383
2003 Raghavan R, Balani J, Perry A, Margraf L, Vono MB, Cai DX, Wyatt RE, Rushing EJ, Bowers DC, Hynan LS, White CL. Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. Journal of Neuropathology and Experimental Neurology. 62: 530-7. PMID 12769192 DOI: 10.1093/Jnen/62.5.530  0.362
2003 Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Frontiers in Bioscience : a Journal and Virtual Library. 8: a1-9. PMID 12456321 DOI: 10.2741/896  0.382
2003 Perry A. Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain? Advances in Anatomic Pathology. 9: 345-50. PMID 12409643 DOI: 10.1097/00125480-200211000-00003  0.413
2002 Bannykh SI, Perry A, Powell HC, Hill A, Hansen LA. Malignant rhabdoid meningioma arising in the setting of preexisting ganglioglioma: a diagnosis supported by fluorescence in situ hybridization. Case report. Journal of Neurosurgery. 97: 1450-5. PMID 12507148 DOI: 10.3171/Jns.2002.97.6.1450  0.442
2002 Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). Journal of Neuropathology and Experimental Neurology. 61: 1078-84. PMID 12484570 DOI: 10.1093/Jnen/61.12.1078  0.366
2002 Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. Journal of Neuropathology and Experimental Neurology. 61: 947-55. PMID 12430711 DOI: 10.1093/Jnen/61.11.947  0.394
2002 Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. The American Journal of Pathology. 161: 665-72. PMID 12163391 DOI: 10.1016/S0002-9440(10)64222-8  0.386
2002 Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. Journal of Neuropathology and Experimental Neurology. 61: 702-9. PMID 12152785 DOI: 10.1093/Jnen/61.8.702  0.382
2002 Wagner L, Hill DA, Fuller C, Pedrosa M, Bhakta M, Perry A, Dome JS. Treatment of metastatic rhabdoid tumor of the kidney. Journal of Pediatric Hematology/Oncology. 24: 385-8. PMID 12142788 DOI: 10.1097/00043426-200206000-00012  0.357
2002 Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 526-31. PMID 12011257 DOI: 10.1038/Modpathol.3880558  0.37
2001 Sinkre P, Perry A, Cai D, Raghavan R, Watson M, Wilson K, Barton Rogers B. Deletion of the NF2 region in both meningioma and juxtaposed meningioangiomatosis: case report supporting a neoplastic relationship. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 4: 568-72. PMID 11826364 DOI: 10.1007/S10024001-0086-2  0.342
2001 Fuller CE, Pfeifer J, Humphrey P, Bruch LA, Dehner LP, Perry A. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic? Human Pathology. 32: 1102-8. PMID 11679945 DOI: 10.1053/Hupa.2001.28252  0.436
2001 Perry A, Giannini C, Raghavan R, Scheithauer BW, Banerjee R, Margraf L, Bowers DC, Lytle RA, Newsham IF, Gutmann DH. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. Journal of Neuropathology and Experimental Neurology. 60: 994-1003. PMID 11589430 DOI: 10.1093/Jnen/60.10.994  0.382
2001 Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT. Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer. 92: 701-11. PMID 11505418 DOI: 10.1002/1097-0142(20010801)92:3<701::Aid-Cncr1373>3.0.Co;2-7  0.375
2001 Gauvain KM, McKinstry RC, Mukherjee P, Perry A, Neil JJ, Kaufman BA, Hayashi RJ. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. Ajr. American Journal of Roentgenology. 177: 449-54. PMID 11461881 DOI: 10.2214/Ajr.177.2.1770449  0.369
2001 Leonard JR, Cai DX, Rivet DJ, Kaufman BA, Park TS, Levy BK, Perry A. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. Journal of Neurosurgery. 95: 82-8. PMID 11453402 DOI: 10.3171/Jns.2001.95.1.0082  0.389
2001 Perry A. Oligodendroglial neoplasms: current concepts, misconceptions, and folklore. Advances in Anatomic Pathology. 8: 183-99. PMID 11444508 DOI: 10.1097/00125480-200107000-00001  0.335
2001 Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. The American Journal of Pathology. 159: 57-61. PMID 11438454 DOI: 10.1016/S0002-9440(10)61673-2  0.364
2001 Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. Journal of Neuropathology and Experimental Neurology. 60: 628-36. PMID 11398839 DOI: 10.1093/Jnen/60.6.628  0.341
2001 Perry A, Scheithauer BW, Szczesniak DM, Atkinson JL, Wald JT, Hammak JE. Combined oligodendroglioma/pleomorphic xanthoastrocytoma: a probable collision tumor: case report. Neurosurgery. 48: 1358-61. PMID 11383742 DOI: 10.1097/00006123-200106000-00038  0.365
2001 Li J, Perry A, James CD, Gutmann DH. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas Neurology. 56: 885-890. PMID 11294925 DOI: 10.1212/Wnl.56.7.885  0.336
2001 Fuller CE, Perry A. Pathology of low- and intermediate-grade gliomas. Seminars in Radiation Oncology. 11: 95-102. PMID 11285547 DOI: 10.1053/Srao.2001.21412  0.416
2001 Bruch LA, Hill DA, Cai DX, Levy BK, Dehner LP, Perry A. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Human Pathology. 32: 156-62. PMID 11230702 DOI: 10.1053/Hupa.2001.21572  0.419
2001 Cai DX, James CD, Scheithauer BW, Couch FJ, Perry A. PS6K amplification characterizes a small subset of anaplastic meningiomas. American Journal of Clinical Pathology. 115: 213-8. PMID 11211609 DOI: 10.1309/Fvnu-7Uby-Dxe3-77Mt  0.374
2000 Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. Journal of Neuropathology and Experimental Neurology. 59: 872-9. PMID 11079777 DOI: 10.1093/Jnen/59.10.872  0.421
2000 Gutmann DH, Donahoe J, Brown T, James CD, Perry A. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas Neuropathology and Applied Neurobiology. 26: 361-367. PMID 10931370 DOI: 10.1046/J.1365-2990.2000.00258.X  0.312
2000 Cai DX, Mafra M, Schmidt RE, Scheithauer BW, Park TS, Perry A. Medulloblastomas with extensive posttherapy neuronal maturation. Report of two cases. Journal of Neurosurgery. 93: 330-4. PMID 10930022 DOI: 10.3171/Jns.2000.93.2.0330  0.373
2000 Smith JS, Tachibana I, Lee HK, Qian J, Pohl U, Mohrenweiser HW, Borell TJ, Hosek SM, Soderberg CL, von Deimling A, Perry A, Scheithauer BW, Louis DN, Jenkins RB. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes, Chromosomes & Cancer. 29: 16-25. PMID 10918389 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1007>3.3.Co;2-9  0.328
2000 Smith JS, Tachibana I, Lee HK, Qian J, Pohl U, Mohrenweiser HW, Borell TJ, Hosek SM, Soderberg CL, Deimling Av, Perry A, Scheithauer BW, Louis DN, Jenkins RB. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers: Mapping of the Glioma 19q Tumor Suppressor Gene Genes, Chromosomes and Cancer. 29: 16-25. PMID 10918389 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1007>3.0.Co;2-I  0.354
2000 Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Human Molecular Genetics. 9: 1495-500. PMID 10888600 DOI: 10.1093/Hmg/9.10.1495  0.403
2000 Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 636-45. PMID 10653879 DOI: 10.1200/Jco.2000.18.3.636  0.376
1999 Halper J, Jung C, Perry A, Suliman H, Hill MP, Scheithauer B. Expression of TGFalpha in meningiomas. Journal of Neuro-Oncology. 45: 127-34. PMID 10778728 DOI: 10.1023/A:1006365725033  0.408
1999 Perry A, Anderl K, Borell TJ, Kimmel DW, Wang CH, O'Fallon JR, Feuerstein BG, Scheithauer BW, Jenkins RB. Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas American Journal of Clinical Pathology. 112: 801-809. PMID 10587703 DOI: 10.1093/Ajcp/112.6.801  0.343
1999 Couce ME, Perry A, Webb P, Kepes JJ, Scheithauer BW. Fibrous meningioma with tyrosine-rich crystals. Ultrastructural Pathology. 23: 341-5. PMID 10582272 DOI: 10.1080/019131299281491  0.314
1999 Adlakha A, Rao K, Adlakha H, Perry A, Crotty TB, Scheithauer BW, Ryu JH. Meningioma metastatic to the lung. Mayo Clinic Proceedings. 74: 1129-33. PMID 10560602 DOI: 10.4065/74.11.1129  0.404
1999 Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene. 18: 4144-52. PMID 10435596 DOI: 10.1038/Sj.Onc.1202759  0.328
1999 Perry A, Scheithauer BW, Zaias BW, Minassian HV. Aggressive enterogenous cyst with extensive craniospinal spread: case report. Neurosurgery. 44: 401-4; discussion 40. PMID 9932896 DOI: 10.1097/00006123-199902000-00098  0.334
1999 Soheithuer BW, Perry A, Stafford SL, Lohse CM, Wollan PC. “MALIGNANCY” IN MENINGIOMAS Journal of Neuropathology and Experimental Neurology. 58: 524. DOI: 10.1097/00005072-199905000-00072  0.34
1998 Perry A, Scheithauer BW, Stafford SL, Abell-Aleff PC, Meyer FB. "Rhabdoid" meningioma: an aggressive variant. The American Journal of Surgical Pathology. 22: 1482-90. PMID 9850174 DOI: 10.1097/00000478-199812000-00005  0.448
1998 Perry A, Stafford SL, Scheithauer BW, Abell-Aleff PC, Meyer FB. “RHABDOID” MENINGIOMA Journal of Neuropathology and Experimental Neurology. 57: 488. DOI: 10.1097/00005072-199805000-00086  0.34
1997 Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. The American Journal of Surgical Pathology. 21: 1455-1465. PMID 9414189 DOI: 10.1097/00000478-199712000-00008  0.383
1997 Perry A, Scheithauer BW, Nascimento AG. The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. The American Journal of Surgical Pathology. 21: 1354-1360. PMID 9351573 DOI: 10.1097/00000478-199711000-00010  0.423
1997 Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA. Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR Journal of Neuropathology and Experimental Neurology. 56: 999-1008. PMID 9291941 DOI: 10.1097/00005072-199709000-00005  0.326
1997 Perry A, Tonk V, McIntire DD, White CL. Interphase cytogenetic (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy. American Journal of Clinical Pathology. 108: 166-74. PMID 9260757 DOI: 10.1093/Ajcp/108.2.166  0.337
1997 Perry A, Giannini C, Scheithauer BW, Rojiani AM, Yachnis AT, Seo IS, Johnson PC, Kho J, Shapiro S. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. The American Journal of Surgical Pathology. 21: 763-71. PMID 9236832 DOI: 10.1097/00000478-199707000-00004  0.351
1997 Giannini C, Scheithauer BW, Jenkins RB, Erlandson RA, Perry A, Borell TJ, Hoda RS, Woodruff JM. Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature. The American Journal of Surgical Pathology. 21: 164-73. PMID 9042282 DOI: 10.1097/00000478-199702000-00005  0.374
1996 Stafford SL, Perry A, Suman V, Meyer FB, Scheithauer BW, Shaw EG, Earle JD. Meningiomas: Outcomes and Analysis of Prognostic Factors of Primarily Resected Tumors Paper #745 Neurosurgery. 39: 648. DOI: 10.1227/00006123-199609000-00095  0.363
1996 Stafford SL, Perry A, Suman V, Meyer FB, Scheithauer BW, Shaw EG, Earle JD. Meningiomas: Outcomes and Analysis of Prognostic Factors of Primarily Resected Tumors Neurosurgery. 39: 648-648. DOI: 10.1097/00006123-199609000-00095  0.369
1996 Stafford S, Perry A, Suman V, Meyer B, Scheithauer B, Shaw E, Earle J. 2018 Eningiomas: Outcome, and analysis of prognostic factors of primarily resected tumors International Journal of Radiation Oncology*Biology*Physics. 36: 287. DOI: 10.1016/S0360-3016(97)85597-6  0.363
1994 Perry A, Wiley EL, Albores-Saavedra J. Pagetoid spread of intratubular germ cell neoplasia into rete testis: a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors. Human Pathology. 25: 235-9. PMID 7512072 DOI: 10.1016/0046-8177(94)90193-7  0.387
Show low-probability matches.